Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,721.18
(
0.29%
)
News Focus
News Focus
Post# of 257266
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

read_this_n0w

Send PM Follow Ignore
Followers 250
Posts 14020
Boards Moderated 3
Alias Born 07/07/2006

read_this_n0w

Re: read_this_n0w post# 85356

Friday, 10/23/2009 6:09:01 PM

Friday, October 23, 2009 6:09:01 PM

Post# of 257266
MYRX The Company expects to report interim results from the ongoing Phase 2 trial of Azixa in metastatic melanoma at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics meeting in Boston in November 2009.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today